JIE CHEN: Open Payments
NPI 1336410398 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,175 in 329 payments from 20 companies in 2025. Trend: 2023 $5,903 · 2024 $5,849 · 2025 $6,175
Food & beverage: $6,070Education: $105
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 36 | $768 |
| Arcutis Biotherapeutics, Inc. | 17 | $664 |
| Janssen Biotech, Inc. | 29 | $657 |
| Galderma Laboratories, L.P. | 22 | $547 |
| UCB, Inc. | 41 | $540 |
| Novartis Pharmaceuticals Corporation | 35 | $395 |
| E.R. Squibb & Sons, L.L.C. | 27 | $388 |
| ABBVIE INC. | 19 | $366 |
| PFIZER INC. | 24 | $357 |
| Lilly USA, LLC | 17 | $331 |
Products named: ILUMYA, Zoryve, TREMFYA, Bimzelx, NEMLUVIO, COSENTYX, CIBINQO, Sotyktu.
Industry payments across MA — which companies pay providers there.
